Update on the management of non-anti D antibodies.
With the development of the Rh D immunoglobulin and utilisation in clinical practice, severe rhesus iso-immunisation is rarely seen today. Antibodies against other blood groups are now more common than anti-D and while the majority do not cause significant haemolysis, there are reports of serious morbidity with antibodies other than anti-D. We reviewed retrospectively all cases (excluding anti-D and anti kell antibodies) where antibodies were detected at routine booking visit between 1997-2001 and correlated the type of antibody to clinical outcome as assessed by coombs test, postnatal phototherapy and transfusion. Our approach to these cases does not involve invasive test as amniocentesis and relies on the ultrasound monitoring, level of antibodies and timely delivery with appropriate paediatric follow up. Over five years period 150 women were identified with antibodies other than anti-D or anti-kell. There were no directly related deaths. Many authorities suggest amniocentesis for specific antibodies to assess fetal haemolysis and plan management. This study support a non-invasive approach with mortality and minimal morbidity.
National Maternity Hospital, Holles St, Dublin 2. sohatohamy@hotmail.com
S
S
Said
P
P
McParland
D001789:Blood Group Antigens; D004899:Erythroblastosis, Fetal / Q000000981:diagnostic imaging / Q000628:therapy*; D005260:Female; D006801:Humans; D007494:Ireland; D011247:Pregnancy; D011295:Prenatal Care; D012189:Retrospective Studies; D012203:Rh Isoimmunization / Q000517:prevention & control*; D018029:Rho(D) Immune Globulin / Q000008:administration & dosage*; D014463:Ultrasonography
D001789:Blood Group Antigens; D018029:Rho(D) Immune Globulin